JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Начало・Списък с акции・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Odonate Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

1.11.2025 г., 12:56 ч. UTC

Печалби

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

1.11.2025 г., 12:56 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1.11.2025 г., 12:20 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1.11.2025 г., 12:19 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1.11.2025 г., 08:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

1.11.2025 г., 08:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

1.11.2025 г., 05:00 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Hathaway Probably Had a Stellar Quarter. Stock Buybacks Are a Wild Card. -- Barrons.com

1.11.2025 г., 00:10 ч. UTC

Печалби

Trouble on The Strip -- Barrons.com

31.10.2025 г., 23:09 ч. UTC

Печалби

Review & Preview: October Surprise -- Barrons.com

31.10.2025 г., 22:44 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31.10.2025 г., 21:25 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31.10.2025 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31.10.2025 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31.10.2025 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31.10.2025 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31.10.2025 г., 20:51 ч. UTC

Придобивния, сливания и поглъщания

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

31.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

31.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Печалби

Auto & Transport Roundup: Market Talk

31.10.2025 г., 20:46 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31.10.2025 г., 20:22 ч. UTC

Печалби

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31.10.2025 г., 20:02 ч. UTC

Печалби

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31.10.2025 г., 19:55 ч. UTC

Пазарно говорене

Crude Futures Fall for Third Straight Month -- Market Talk

31.10.2025 г., 19:54 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31.10.2025 г., 19:54 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31.10.2025 г., 19:26 ч. UTC

Пазарно говорене

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31.10.2025 г., 18:30 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31.10.2025 г., 18:23 ч. UTC

Пазарно говорене

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31.10.2025 г., 18:09 ч. UTC

Печалби

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31.10.2025 г., 18:08 ч. UTC

Печалби

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Odonate Therapeutics Inc Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.